Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
- Hikaru Sasaki
- , Yohei Kitamura
- , Masahiro Toda
- , Yuichi Hirose
- , Kazunari Yoshida
研究成果: Review article › 査読
8
リンクは新しいタブで開きます
被引用数
(Scopus)